XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenues from sales of products $ 63,566 $ 129,733
Cost of sales (4,911) (64,994) (25,686) (99,035)
Gross profit (4,911) (64,994) 37,880 30,698
Research and development expenses (95,707) (87,177) (253,343) (219,003)
Selling and marketing expenses (7,811) (111,599) (36,748) (258,161)
General and administrative expenses (295,297) (264,603) (513,376) (427,751)
Operating loss (403,726) (528,373) (765,587) (874,217)
Financing expenses, net (193,149) (7,816) (200,351) (21,318)
Share in losses of affiliated company (6,382) (6,382)
Gain on disposal of affiliated company 15,690 15,690
Net loss (581,185) (542,571) (950,248) (901,917)
Less: Net loss attributable to non-controlling interests 4,140 5,148 7,556 8,732
Net loss attributable to the Company $ (577,045) $ (537,423) $ (942,692) $ (893,185)
Loss per share (basic and diluted) $ (0.06) $ (0.05) $ (0.09) $ (0.09)
Basic and diluted weighted average number of shares of common stock outstanding 10,209,487 9,872,441 10,209,487 9,741,521